A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck.

Chun, Stephen G; Hughes, Randall; Sumer, Baran D; Myers, Larry L; Truelson, John M; Khan, Saad A; Ma, Tsung-Wei; Xie, Yang; Yordy, John S; Cooley, Susan; Wu, Jean; Choy, Hak; Nedzi, Lucien A

Chun, Stephen G; Hughes, Randall; Sumer, Baran D; Myers, Larry L; Truelson, John M; Khan, Saad A; Ma, Tsung-Wei; Xie, Yang; Yordy, John S; Cooley, Susan; Wu, Jean; Choy, Hak; Nedzi, Lucien A.

Afiliação

Chun SG; a Division of Radiation Oncology, M.D. Anderson Comprehensive Cancer Center , Houston , TX , USA.
Hughes R; b Division of Hematology and Oncology, Department of Internal Medicine, Harold C. Simmons Cancer Center, University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Sumer BD; c Department of Otolaryngology , University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Myers LL; c Department of Otolaryngology , University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Truelson JM; c Department of Otolaryngology , University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Khan SA; b Division of Hematology and Oncology, Department of Internal Medicine, Harold C. Simmons Cancer Center, University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Ma TW; d Department of Clinical Sciences , University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Xie Y; d Department of Clinical Sciences , University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Yordy JS; e Valley Radiation Therapy Center , Anchorage , AK , USA.
Cooley S; f Department of Radiation Oncology , Harold C. Simmons Comprehensive Cancer Center, University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Wu J; f Department of Radiation Oncology , Harold C. Simmons Comprehensive Cancer Center, University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Choy H; f Department of Radiation Oncology , Harold C. Simmons Comprehensive Cancer Center, University of Texas at Southwestern Medical Center , Dallas , TX , USA.
Nedzi LA; f Department of Radiation Oncology , Harold C. Simmons Comprehensive Cancer Center, University of Texas at Southwestern Medical Center , Dallas , TX , USA.

Cancer Invest ; 35(1): 23-31, 2017 Jan 02.

Article em En | MEDLINE | ID: mdl-27892728

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem; Carcinoma de Células Escamosas/tratamento farmacológico; Neoplasias de Cabeça e Pescoço/tratamento farmacológico; Neoplasias de Cabeça e Pescoço/radioterapia; Idoso; Albuminas/administração & dosagem; Albuminas/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Cetuximab/administração & dosagem; Cetuximab/uso terapêutico; Cisplatino/administração & dosagem; Cisplatino/uso terapêutico; Terapia Combinada; Feminino; Humanos; Masculino; Dose Máxima Tolerável; Pessoa de Meia-Idade; Paclitaxel/administração & dosagem; Paclitaxel/uso terapêutico; Análise de Sobrevida; Resultado do Tratamento

Palavras-chave

Abraxane; cisplatin; erbitux; head and neck cancer; radiation therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Cabeça e Pescoço Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Invest Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google